Management of Peyronie’s Disease: AUA 2015 Guidelines

Posted by Alan W. Shindel, MD, MAS | Jul 2019

Alan W. Shindel, MD, MAS, presented “Management of Peyronie’s Disease: AUA 2015 Guidelines” during the Jackson Hole Seminars on February 2, 2019 in Jackson Hole, Wyoming.

How to cite: Shindel, Alan W. “Management of Peyronie’s Disease: AUA 2015 Guidelines” February 2, 2019. Accessed [date today]. https://dev.grandroundsinurology.com/management-of-peyronies-disease-aua-2015-guidelines/

Management of Peyronie’s Disease: AUA 2015 Guidelines – Summary

Alan W. Shindel, MD, MAS, explains the current evidence-based recommendations for Peyronie’s disease as described in the 2015 American Urological Association (AUA) guidelines, emphasizing the shared decision-making aspect of these guidelines. He provides an overview of the recommendations regarding the diagnosis of this condition, as well as medical therapy, injections, and surgical repair options.

About the Ralph E. Hopkins Urology Seminar

The Ralph E. Hopkins Urology Seminar, or Jackson Hole Seminars (JHS), is a multi-day conference that focuses on patient safety and cutting-edge updates in the assessment, diagnosis, and treatment of urologic conditions. The topics discussed include urologic cancers, stone disease, urologic reconstruction, female urology, infertility, emerging surgical techniques, and general urology. In addition to didactic expert lectures, this conference features a unique interactive critique panel. Dr. Shindel presented this lecture during the 39th Annual JHS. Please visit this page in order to register for future JHS meetings.

About The Author

Alan W. Shindel, MD, MAS

Alan W. Shindel, MD, MAS, graduated from the School of Medicine at Washington University in Saint Louis, Missouri, in 2002. He completed his residency training in urology at Barnes-Jewish Hospital in 2007. After completion of his residency, he started a 3-year Research and Clinical Fellowship in Andrology (Men’s Reproductive and Sexual Health) at the University of California, San Francisco (UCSF), under the direction of Drs. Tom Lue and Ira Sharlip. He joined the urology faculty at the University of California, Davis (UC Davis) in 2010 as an Assistant Professor of Urology. He was promoted to Associate Professor of Urology there in 2014. His clinical practice at that time was directed toward the care of patients with sexual concerns, urinary tract symptoms, and chronic pain syndromes. During his time at UC Davis, he served in various capacities on the Medical School Admissions Committee and was Director of the Medical Student Rotations in Urology. He was the Inaugural Editor-in-Chief for Sexual Medicine, an open access journal of the International Society for Sexual Medicine, from 2012 to 2015, and served on the board of the Sexual Medicine Society of North America from 2013 to 2015. In 2015, he left UC Davis to serve as a Medical Director at Genomic Health Inc., a manufacturer of genomic-based tests for prostate cancer. After two years at Genomic Health Inc., Dr. Shindel returned to UCSF in 2017 as an Associate Professor of Urology. He also currently serves as Interim Vice Chair of Education and Interim Residency Program Director at UCSF. Dr. Shindel has authored over 150 manuscripts and commentaries published as peer-reviewed original research, reviews, book chapters, and/or patient information pieces on topics including sexual dysfunction in men and women, urinary tract symptoms, nutritional supplements, urologic cancers, and medical education.

Join the GRU Community

- Why Join? -

CARDEN JENNINGS PUBLISHING CO., LTD.

Your GRU

– Account Dashboard
– Your Courses

Recent Updates

PDF Embedder Test Jan 2022
Genetic Testing and Prostate Cancer – Welcome Jan 2022
Current Status of PSMA Diagnostics Aug 2021
Genetic Testing and Prostate Cancer Aug 2021
What’s New in Active Surveillance for Prostate Cancer in 2021 Aug 2021

Exercise & Wellness

Share This